Celularity
CELU
21 hedge funds and large institutions have $8.42M invested in Celularity in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 21 closing their positions.
979% more call options, than puts
Call options by funds: $11.7M | Put options by funds: $1.08M
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
3.11% less ownership
Funds ownership: 3.21% → 0.1% (-3.1%)
36% less funds holding
Funds holding: 33 → 21 (-12)
57% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 21
91% less capital invested
Capital invested by funds: $93.8M → $8.42M (-$85.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
HF
HRT Financial
New York
|
+$567K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$537K |
| 3 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$323K |
| 4 |
Morgan Stanley
New York
|
+$320K |
| 5 |
Jane Street
New York
|
+$247K |
Top Sellers
| 1 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$20.9M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$15.7M |
| 3 |
TAL
TIG Advisors LLC
New York
|
-$10.6M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$7.33M |
| 5 |
MSU
Mizuho Securities USA
New York
|
-$5.62M |
CELU Hedge Fund Activity: Q3 2021 in Review
21 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2021, worth a combined $8.42M — down 91% from $93.8M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of CELU and 9 opened new positions — a net loss of 12 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was HRT Financial, adding an estimated $567K. The largest seller was W.R. Berkley Corp, exiting entirely with an estimated $20.9M sold.
- 21 institutional investors held Celularity (CELU) as of Q3 2021, down from 33 in Q2 2021.
- Funds reported $8.42M of Celularity stock for Q3 2021, down 91% quarter-over-quarter.
- 9 funds opened new Celularity positions in Q3 2021 and 21 closed out, a net change of -12 holders.
- The largest Celularity buyer in Q3 2021 was HRT Financial, an estimated $567K added.
- The largest Celularity seller in Q3 2021 was W.R. Berkley Corp, an estimated $20.9M sold.
Based on aggregated 13F filings for Q3 2021.